Fundamental Analysis
39 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -43.6% | -59.1% | 0 / 3 | -67.7% | +25.26 pp | +5.95 pp | +11.0% | 1.30 | 3.62 | 221 | −67,7% | 28,8 | −40,5% | 3.62 | 6.68 | −45,9% |
| Pts | 0 | 0 | 0 | 0 | 12 | 12 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 10.500 (close price on 2026-10-19)EPS (TTM): 2.903
Financial charts
1.Revenue & growth
VND bn221Q2/26
1.Revenue & growth
VND bn221Q2/26
2.Profit & growth
VND bn24,5Q2/26
3.Profit mix (Penman)
VND bn166Q2/26
4.Margins & cost structure
%29.6%Q2/26
5.Returns & cash cycle
% · days9.3%Q2/26
6.Earnings quality & cash
VND bn-651Q2/26
7.Asset structure
VND bn4.184Q2/26
8.Funding & debt health
VND bn · times4.184Q2/26
9.Revenue backlog
VND bn234Q2/26
10.Valuation
times · %3,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %611Q2/26
Adjusted EPS growth, latest quarter
-67.8%
Average adjusted EPS growth, 3 quarters
-67.2%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
65.5%
Source: vnstockData through Q2/26